<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Patient-Derived Xenografts as Models for Metastatic Breast Cancer and Preclinical Therapy Testing

Breast cancer is a highly heterogeneous, complex disease affecting millions of women worldwide. While treatment advances are being made across targeted and immunotherapies, the preclinical research community still faces the challenge of finding more reliable, translatable models.